Why India's Blue Bioeconomy Needs Platform Thinking
India has biological abundance, scientific capability and industrial demand. The missing layer is a repeatable system that converts these strengths into validated technologies.
India’s marine economy contains an unusual combination of feedstock diversity, coastal communities, scientific institutions and large downstream markets. Yet much of the value is still captured through low-value commodity pathways.
LipiCure’s working thesis is that the gap is not simply one missing product. It is the absence of an integrated translation platform connecting market intelligence, scientific research, digital process development, validation and commercialisation.
From isolated projects to a reusable platform
A product-by-product approach repeatedly rebuilds the same capabilities. A platform approach accumulates knowledge, data, collaborators, process models and commercial insight across multiple programs.
- •Start with validated industrial needs
- •Use digital models to prioritise experiments
- •Advance scientific and market evidence together
- •Package validated know-how for licensing and scale-up
What LipiCure is building
Omega-3 is the first demonstration project. The larger ambition is a repeatable marine biotechnology innovation system capable of supporting multiple products and technologies over time.